Daiichi Sankyo is ready to defend itself in court after Asia’s largest private healthcare group filed a lawsuit alleging that Daiichi unlawfully interfered with its business activities. The plaintiff is seeking more than 20 billion yen ($131 million) in damages.
The Japanese pharmaceutical company has been in a long-standing conflict with the billionaire co-founders of an Indian hospital network that the plaintiff — IHH Healthcare Berhad — tried to buy shares of five years ago. On Nov. 13, IHH submitted a complaint against Daiichi at the Tokyo District Court connected with the botched acquisition attempt.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.